CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: Suvorexant in Insomnia Co-morbid With Fibromyalgia [Phase 4]
Summary
Phase 4 trial update on suvorexant for insomnia co-morbid with fibromyalgia; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Henry Ford Health System | Conditions: Insomnia, Fibromyalgia | Phase 4 | Status: TERMINATED | Results posted: 2021-04-28